Renalytix plc (NASDAQ: RNLX)
$0.34
+0.0092 ( +2.79% ) 1.5M
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Market Data
Open
$0.34
Previous close
$0.33
Volume
1.5M
Market cap
$26.54M
Day range
$0.28 - $0.35
52 week range
$0.22 - $3.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 3 | Mar 19, 2024 |
8-k | 8K-related | 13 | Mar 14, 2024 |
8-k | 8K-related | 15 | Mar 13, 2024 |
8-k | 8K-related | 13 | Mar 04, 2024 |
8-k | 8K-related | 12 | Feb 29, 2024 |
8-k | 8K-related | 14 | Feb 15, 2024 |
10-q | Quarterly Reports | 71 | Feb 14, 2024 |
8-k | 8K-related | 14 | Feb 09, 2024 |
8-k | 8K-related | 12 | Jan 17, 2024 |
8-k | 8K-related | 12 | Jan 10, 2024 |